News

AcadeMab has initiated a phase I clinical trial at multiple clinical centers, including National Taiwan University Hospital, National Taiwan University Cancer Center, and National Cheng Kung University Hospital.
14
Sep,2023
News

AcadeMab has initiated a phase I clinical trial at multiple clinical centers, including National Taiwan University Hospital, National Taiwan University Cancer Center, and National Cheng Kung University Hospital.

The first subject of this trail has enrolled, and a total of 30 subjects are expected to participate in this clinical trial.

AcadeMab Biomedical and Academia Sinica enter into exclusive license agreement for dengue fever mRNA vaccine and Potent cationic lipids
01
Sep,2023
News

AcadeMab Biomedical and Academia Sinica enter into exclusive license agreement for dengue fever mRNA vaccine and Potent cationic lipids

Academia Sinica and AcadeMab Biomedical have reached an exclusive licensing agreement.

BACK


Verification

Click the numbers in sequence.

academab.com may set and access academab.com cookies on your computer.  Cookies are used to provide our system with the basic information to provide the services you are requesting.  Cookies can be cleared at any time from your internet browser settings. 

 

Cookies Cookies

Privacy preference center

academab.com may set and access academab.com cookies on your computer.  Cookies are used to provide our system with the basic information to provide the services you are requesting.  Cookies can be cleared at any time from your internet browser settings. 

 

Privacy Privacy

Manage Consent Settings

Necessary Cookies

Enable All

網站運行離不開這些 Cookie 且您不能在系統中將其關閉。通常僅根據您所做出的操作(即服務請求)來設置這些 Cookie,如設置隱私偏好、登錄或填充表格。您可以將您的瀏覽器設置為阻止或向您提示這些 Cookie,但可能會導致某些網站功能無法工作。